about
Structural basis for the inhibition of activin signalling by follistatin.Ion mobility-mass spectrometry for structural proteomicsA Redox-Active, Compact Molecule for Cross-Linking Amyloidogenic Peptides into Nontoxic, Off-Pathway Aggregates: In Vitro and In Vivo Efficacy and Molecular Mechanisms.Activation state-selective kinase inhibitor assay based on ion mobility-mass spectrometryIon mobility-mass spectrometry of intact protein--ligand complexes for pharmaceutical drug discovery and development.Robotically assisted titration coupled to ion mobility-mass spectrometry reveals the interface structures and analysis parameters critical for multiprotein topology mappingAspects of native proteins are retained in vacuum.Collisional and Coulombic unfolding of gas-phase proteins: high correlation to their domain structures in solution.Bound anions differentially stabilize multiprotein complexes in the absence of bulk solvent.Integrating mass spectrometry of intact protein complexes into structural proteomicsTraveling-wave Ion Mobility-Mass Spectrometry Reveals Additional Mechanistic Details in the Stabilization of Protein Complex Ions through Tuned Salt Additives.Dramatically stabilizing multiprotein complex structure in the absence of bulk water using tuned Hofmeister salts.Surface-induced dissociation on a MALDI-ion mobility-orthogonal time-of-flight mass spectrometer: sequencing peptides from an "in-solution" protein digest.Oligonucleotide analysis with MALDI-ion-mobility-TOFMS.The structure of gas-phase bradykinin fragment 1-5 (RPPGF) ions: an ion mobility spectrometry and H/D exchange ion-molecule reaction chemistry study.A study of peptide-peptide interactions using MALDI ion mobility o-TOF and ESI mass spectrometry.Distinguishing between phosphorylated and nonphosphorylated peptides with ion mobility-mass spectrometry.Characterization of symmetric complexes of nerve growth factor and the ectodomain of the pan-neurotrophin receptor, p75NTRIon mobility-mass spectrometry reveals long-lived, unfolded intermediates in the dissociation of protein complexes.Subunit architecture of intact protein complexes from mass spectrometry and homology modeling.Tandem differential mobility analysis-mass spectrometry reveals partial gas-phase collapse of the GroEL complex.Integrating ion mobility mass spectrometry with molecular modelling to determine the architecture of multiprotein complexesA rationally designed small molecule for identifying an in vivo link between metal-amyloid-β complexes and the pathogenesis of Alzheimer's disease.Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease.Evidence for macromolecular protein rings in the absence of bulk water.Analysis of a soluble (UreD:UreF:UreG)2 accessory protein complex and its interactions with Klebsiella aerogenes urease by mass spectrometry.Mass spectrometry: come of age for structural and dynamical biology.Variable-Velocity Traveling-Wave Ion Mobility Separation Enhancing Peak Capacity for Data-Independent Acquisition Proteomics.Bound cations significantly stabilize the structure of multiprotein complexes in the gas phase.Reactivity of diphenylpropynone derivatives toward metal-associated amyloid-β species.Insights into antiamyloidogenic properties of the green tea extract (-)-epigallocatechin-3-gallate toward metal-associated amyloid-β speciesResolution of oligomeric species during the aggregation of Aβ1-40 using (19)F NMR.Complex Formed between Intramembrane Metalloprotease SpoIVFB and Its Substrate, Pro-σKAmyloid-β-neuropeptide interactions assessed by ion mobility-mass spectrometry.Protein complexes in the gas phase: technology for structural genomics and proteomics.A single subunit directs the assembly of the Escherichia coli DNA sliding clamp loader.Hofmeister salts recover a misfolded multiprotein complex for subsequent structural measurements in the gas phaseExploring the reactivity of flavonoid compounds with metal-associated amyloid-β species.Ion Mobility-Mass Spectrometry Differentiates Protein Quaternary Structures Formed in Solution and in Electrospray Droplets.A Multidimensional Analytical Comparison of Remicade and the Biosimilar Remsima.
P50
Q24304947-8A875983-B982-4766-AD48-49D22F589F77Q26826931-8F67F169-BA16-43CF-A3ED-5606AFECFEF1Q27336229-4EFC2EA8-44A0-44DC-8ED6-A4686C6C1B44Q30352015-A95C65FA-62F4-4874-A30B-C24E73B5A7AEQ30352096-B0078ACD-AD80-43F4-BCB5-3C0702FDB94FQ30354958-3C1C3AE5-43E1-4151-AD66-FE2D23BFF59DQ30356497-54CB5061-718A-4304-B330-79E52958E215Q30364286-8225857C-C516-4817-8A83-FB8BCADDC08AQ30403879-4233C09A-E8D6-4469-9B6D-6E0AD74EE184Q30417001-20D34277-FB89-4C86-BE27-E13E455241D3Q30428856-F0E80980-E77A-42D3-B418-B0905FA2CE1BQ30432313-A705CF26-BC12-4BCD-98D7-EE097C4BB0BDQ30675909-BC269C41-B06F-46FD-892F-3E99CD514496Q30843725-603C4BAB-A1FC-49C7-81CA-A82849D65E14Q31170814-50BAC57D-6BE8-4C7C-8723-7CD7A24866C2Q32062428-BCF31BBD-B9A4-4FBE-8309-9D54E2046CBAQ33186444-1BB6EE33-D514-4220-B1F1-2ED74415DD5CQ33218710-762E89F4-992F-4FDA-AAE3-D2EDF161D354Q33298819-726E511B-DCB7-44A9-BEB4-B16C3BAFA356Q33322101-91786118-6433-4D0E-9601-2704BEBD1D2BQ33449716-8C1D4221-194B-4176-B4BA-ACDB1C44D029Q33658957-0EADCE51-B235-48E4-89F3-55986E2488B3Q33863553-5406D5EF-597B-4C1E-A2C5-836A96C62E11Q34055098-935B41D6-A6D8-4BF3-B7D9-40AAF70F9FBFQ34468487-752213D0-49FB-4146-BB0D-FCD68025D7C0Q34782283-8F807FD5-BDFA-4423-B916-8A919F1CC123Q35347233-F01F63D1-48F2-472C-98D9-EB72318E5CABQ36362848-5299B6F7-AD2D-4D66-B77B-721027A3371EQ36452763-453C724D-EF42-4E98-96A0-D568AAAB38C6Q36598558-C2C9ED99-33A2-4EB3-AF3E-E5FA3B97E0E4Q36673287-369FFFC7-7C6A-4062-BAE3-F4B770392D5FQ36772928-B715A1E6-804C-4927-A64E-2407C87CF439Q36876249-FD63C301-B9E1-471A-B0E4-2CC5B788C2CAQ36879051-6114D940-155F-4402-9597-CDAE9E77E80AQ36890557-F90957FF-FA97-4062-9AD2-77342B25C738Q36908642-47158301-C5EC-4E06-961E-7D8981E15B7BQ37202930-22BA8338-0786-483F-9E44-AC2364B1E538Q37222626-95AACCF8-E321-4DEC-B570-51ED92512E3DQ37505705-4F98120E-32E2-43D2-8B38-F35FB7C80E13Q38736575-E2522F77-22AA-4831-B35E-53AD3EFBD30C
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Brandon T Ruotolo
@es
Brandon T. Ruotolo
@en
Brandon T. Ruotolo
@nl
Brandon T. Ruotolo
@sl
type
label
Brandon T Ruotolo
@es
Brandon T. Ruotolo
@en
Brandon T. Ruotolo
@nl
Brandon T. Ruotolo
@sl
prefLabel
Brandon T Ruotolo
@es
Brandon T. Ruotolo
@en
Brandon T. Ruotolo
@nl
Brandon T. Ruotolo
@sl
P1053
F-2669-2013
P106
P1153
6602842677
P21
P31
P3829
P496
0000-0002-6084-2328
P569
2000-01-01T00:00:00Z